Stephan Herzig Receives the 2026 Friedrich Arnold Gries Award from the DDG

DZD News

Prof. Stephan Herzig has been awarded the 2026 Friedrich Arnold Gries Award by the German Diabetes Association (DDG). The award recognizes his outstanding scientific work on “Molecular characterization and therapeutic exploitation of starvation/fasting metabolism”, which has opened new avenues for understanding and treating diabetes-associated complications. The prize is endowed with €10,000 and was sponsored by Boehringer Ingelheim Pharma GmbH & Co. KG.

Stephan Herzig, Director and Head of Department at the Helmholtz Diabetes Center and Director of the Institute for Diabetes and Cancer at Helmholtz Munich, conducts research on the molecular foundations of metabolism and on innovative therapeutic strategies for diabetes and closely related comorbidities. His work bridges fundamental molecular mechanisms with translational research questions and has made a significant contribution to a better understanding of metabolic adaptation processes.

About the Friedrich Arnold Gries Award

The Friedrich Arnold Gries Award is presented to actively conducting medical researchers and scientists for outstanding, therapeutically relevant achievements in the field of microvascular and macrovascular complications of diabetes, as well as closely related diseases such as fatty liver disease. The award honors several outstanding publications or a coherent body of scientific work that has contributed to advances in the prevention, prognosis, and organ protection of diabetes.

Birgit Niesing
Birgit Niesing

Public Relations